We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Guidance for prisons on the reintroduction of disinfecting tablets for use by prisoners.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
The government will place 6 new synthetic opioids under the strictest level of control.
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
Information for patients, healthcare professionals and developers of new medicines
Exeltis UK Limited has informed the MHRA regarding an inconsistency in the Patient Information Leaflet (PIL) packaged in cartons of the specified batches of Gepretix 100mg capsules.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.
Product Safety Report for baby sleep bags presenting a serious risk of suffocation, overheating and death.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).